MemoryGel Breast Implants
Mentor Corp. · Decision date Oct 23, 2026
What did the FDA decide?
This 30-day notice for PMA supplement P030053/S093 records a process change for MemoryGel breast implants. The stated change is the addition of small size packaging tooling on the existing packaging equipment. The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier.
The decision field is OK30, and the supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device is a noninflatable, internal, silicone gel-filled breast prosthesis under product code FTR. The notice does not state a new indication, clinical data, or safety or effectiveness findings. Specific information about the tooling dimensions, affected package sizes, or validation results is absent from the supplied fields.
FDA approval order statement
the addition of small size packaging tooling on the existing packaging equipment
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 23, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P030053/S093
- Regulatory pathway
- PMA supplement
- Applicant
- Mentor Corp.
- Product code
- FTR
- Decision code
- OK30
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
- Applicant
- Mentor Corp.
- Product code
- FTR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P030053. Subsequent supplements may change the device or its indications.
FDA decision timeline
P030053 · Original PMA
MEMORYGEL SILICONE GEL -FILLED BREAST IMPLANTS
P030053/S093 received
Application receipt date recorded by FDA.
P030053/S093 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P030053. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030053
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Mentor Corp. | PMA approval | Nov 17, 2006 | FDA |
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sientra Silicone Gel Breast ImplantsP070004/S049 | Tiger Aesthetics Medical, LLC | PMA supplement | Nov 4, 2026 | FDA |
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA | |
| Allergan | PMA supplement | Sep 29, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Mentor Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 33 Technology Dr., Irvin, CA, 92618
Sources and methodology
- Original FDA record: P030053/S093
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




